Media Release
IMPORTANT NOTIFICATION: Zantac (Ranitidine) Recall
Dear Doctor, Aspen Pharmacare Australia Pty Ltd, in consultation with the Therapeutic Goods Administration (TGA), is conducting a retail level recall of Zantac (ranitidine) tablets, effervescent tablets, syrup and ampoules. The TGA has not requested that a Dear Doctor letter be sent for this retail level product recall. We are informing you as the potentially…
Read MoreANNOUNCEMENT: Divestment of portfolio to Strides
As of 1 September 2015 Aspen has divested to Strides (Australia) Pharma Pty Ltd a portfolio of its products commercialised in Australia and New Zealand. The range primarily includes the Aspen Generics Product Portfolio and business, including the Chemists’ Own range. Strides, to be called Arrow Pharmaceuticals in Australia, has a core focus on generic product development, and with its strong manufacturing and procurement capabilities has better opportunities to promote and grow this portfolio.
Read MoreWINNER Aspen Values Award – JOHN SEGEDIN, Warehouse Leading Hand, Operations, Dandenong
It is with great pleasure and pride we communicate that at the 2014 Aspen Global Recognition Awards held in Johannesburg South Africa on Friday 7 November, John Sedgedin was announced the winner of the Aspen Values Award.
Read More
S26 Original Progress Withdrawal – Update
Aspen Nutritionals takes product safety very seriously and we are in the process of investigating the issue. We have not received any further complaints of this nature.
Read MoreVoluntary Withdrawal of S-26 Original Progress Formula, Batch Number 40727482A2
Aspen Nutritionals Australia Pty Ltd is very concerned that a customer has reported finding a lizard in a tin of S-26 Original Progress formula, and is voluntarily withdrawing the affected batch number 40727482A2 while it investigates the issue. No other products or batches are affected, and consumers can continue to use these with confidence.
Read MoreHonorary Doctor of Commerce Degree conferred on Stephen Saad
Port Elizabeth – The Nelson Mandela Metropolitan University (NMMU) today conferred the degree of Doctor of Commerce (honoris causa) on Stephen Saad, Aspen Group Co-Founder and Chief Executive. Chancellor of the NMMU, Santie Botha said, ‘’It is an honour for NMMU to confer this honorary degree on Stephen Saad. His vision and drive in the world of business is inspiring and as NMMU we acknowledge the turn-around he orchestrated in a Port Elizabeth-based company that provides jobs to people in an economically struggling province’’.
Read MorePerrigo Company plc Announces Acquisition Of OTC Products In Australia
DUBLIN, Feb. 28, 2014 /PRNewswire/ — Perrigo Company plc (NYSE: PRGO;TASE) announced that it has acquired a basket of value-brand OTC products sold in Australia and New Zealand from Aspen Global Inc. for $51 million in cash. The products are primarily sold through the mass retail channel and include the Herron® range of analgesics, vitamins and supplements. This basket of products is expected to generate at least $20 million in annual revenue.
Read MoreNew Supply Conditions Relating to Di-Gesic and Doloxene
On 1 January 2014 new conditions relating to the prescribing and dispensing of Di-Gesic (dextropropoxyphene HCl 32.5mg/paracetamol 325mg) and Doloxene (dextropropoxyphene napsylate) came into effect.
Read MoreDi-Gesic Supply Update
Aspen Pharmacare Australia Pty Ltd wish to advise that Di-Gesic (dextropropoxyphene HCl 32.5mg/paracetamol 325mg)) stock has been released to wholesalers today.
Read MoreAustralian Packaging Covenant – Aspen Report 2013
The Australian Packaging Covenant is a voluntary initiative by Government and Industry to reduce the environmental effects of packaging. It is designed to minimise the environmental impacts arising from the disposal of used packaging, conserve resources through better design and production processes and facilitate the re-use and recycling of used packaging materials. Here you can view Aspen Australia's plan and report.
Read More